The COVID-19 epidemic has been fueled in part by the involvement of some of the largest pharmaceutical corporations in the world.
Aside from that, the flu epidemic has been a boon to the healthcare industry as well. There will still be a total of $851 billion in revenue generated by the world’s 50 top pharmaceutical businesses alone in 2020 alone.
We’ve compiled a list of the world’s biggest pharmaceutical businesses based on their market capitalization using data from Companies Market Cap. In addition to pharmaceutical companies, this list includes biotech, pharmaceutical retailers, clinical laboratories, and other healthcare companies that work closely with pharmaceuticals.
The Pharmaceutical Leaders
To start, here are the top five biggest pharmaceutical companies in the world at the moment by market capitalization:
- Johnson & Johnson
The pharmaceutical and consumer goods giant is worth $428.7 billion in market cap. They developed the third vaccine authorized for use in the U.S. and were named among the TIME100 Most Influential Companies List in 2021.
- Roche
The Swiss pharmaceutical giant is at the forefront of oncology, immunology, infectious diseases, ophthalmology, and neuroscience. In 2019, Roche’s pharma segment sales rose by a healthy 16% to $53 billion.
- Pfizer
Despite being the leading COVID-19 vaccine manufacturer in North America, Pfizer slid in the rankings to third place. The company has recently gained momentum, especially in the past quarter, with Q2’2021 revenues of $19.0 billion, reflecting a 86% operational growth from 2020.
- Eli Lilly
Eli Lilly has taken a significant step towards establishing itself as a pharmaceutical industry leader. Having a market cap value of $125 billion in 2019, Eli Lilly has jumped to a current value of $214.9 billion, a significant growth of 72%.
- Novartis
The second-biggest pharmaceutical company out of Switzerland, Novartis has been the face of the pharma industry for about 25 years. The primary manufacturer for the most recognizable drugs on the market pulled in a revenue of over $48 billion in 2020, a 3% increase compared to 2019.
